• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent.奥密克戎和德尔塔变异株的双重组合引发了 COVID-19 病例的海啸式高浪:这是一个具有挑战性的全球威胁,特别关注印度次大陆。
J Med Virol. 2022 May;94(5):1761-1765. doi: 10.1002/jmv.27585. Epub 2022 Feb 12.
2
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.与 SARS-CoV-2 三种主要变异株相关的临床结果和系统进化分析。
Eur J Clin Invest. 2023 Sep;53(9):e14004. doi: 10.1111/eci.14004. Epub 2023 May 2.
3
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?奥密克戎变异株(B.1.1.529)及其亚谱系:在 SARS-CoV-2 重组变异株出现之际,我们目前了解多少?
Biomed Pharmacother. 2022 Oct;154:113522. doi: 10.1016/j.biopha.2022.113522. Epub 2022 Aug 15.
4
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.SARS-CoV-2 的分子进化:2019 年 12 月至 2022 年 8 月。
J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366.
5
Omicron variant in COVID-19 current pandemic: a reason for apprehension.奥密克戎变异株在当前 COVID-19 大流行中的出现:令人担忧的原因。
Horm Mol Biol Clin Investig. 2022 Sep 5;44(1):89-96. doi: 10.1515/hmbci-2022-0010. eCollection 2023 Mar 1.
6
Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.美国亚利桑那州公共临床检测、医院和社区污水的基线测序监测显示,SARS-CoV-2 关注的奥密克戎变异株迅速出现。
mBio. 2023 Feb 28;14(1):e0310122. doi: 10.1128/mbio.03101-22. Epub 2023 Jan 9.
7
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.全球新兴的 SARS-CoV-2 奥密克戎变异株:影响、挑战与策略。
J Infect Public Health. 2023 Jan;16(1):4-14. doi: 10.1016/j.jiph.2022.11.024. Epub 2022 Nov 19.
8
Current surge of COVID-19 infection in China and its impact on India.中国当前 COVID-19 感染的激增及其对印度的影响。
Indian J Med Microbiol. 2023 Mar-Apr;42:46-48. doi: 10.1016/j.ijmmb.2023.01.010. Epub 2023 Feb 2.
9
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.在墨西哥西部,比较感染野生型 SARS-CoV-2、Delta 或 Omicron 变异株的个体的症状、合并症和再感染的流行情况:一项比较研究。
Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023.
10
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.

引用本文的文献

1
Multipronged strategy for protection and motivation of healthcare workers during the COVID-19 pandemic: a real-life study.新冠疫情期间医护人员保护与激励的多管齐下策略:一项实际研究
Antimicrob Steward Healthc Epidemiol. 2024 Jul 25;4(1):e101. doi: 10.1017/ash.2023.459. eCollection 2024.
2
Current Updates on Variants of SARS-CoV- 2: Systematic Review.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的最新情况:系统评价
Health Sci Rep. 2024 Nov 4;7(11):e70166. doi: 10.1002/hsr2.70166. eCollection 2024 Nov.
3
Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India.印度中部 SARS-CoV-2 谱系的分子特征和基因组监测。
Viruses. 2024 Oct 14;16(10):1608. doi: 10.3390/v16101608.
4
Cerebral small vessel injury in mice with damage to ACE2-expressing cerebral vascular endothelial cells and post COVID-19 patients.脑内小血管损伤与 ACE2 表达的脑血管内皮细胞损伤和新冠病毒感染后患者相关。
Alzheimers Dement. 2024 Nov;20(11):7971-7988. doi: 10.1002/alz.14279. Epub 2024 Oct 1.
5
Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa.南非开普敦感染奥密克戎新冠病毒的儿童的疾病临床谱及转归
IJTLD Open. 2024 Jan 1;1(1):27-33. doi: 10.5588/ijtldopen.23.0053. eCollection 2024 Jan.
6
SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.2020 年 1 月至 2022 年 1 月期间加拿大艾伯塔省、不列颠哥伦比亚省和安大略省的 SARS-CoV-2 传播情况。
Emerg Infect Dis. 2024 May;30(5):956-967. doi: 10.3201/eid3005.230482.
7
Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.接种 Ad5-nCoV(康希诺)后对 SARS-CoV-2 的 Delta 变异株的中和抗体反应在墨西哥人群中。
PLoS One. 2024 Apr 4;19(4):e0299520. doi: 10.1371/journal.pone.0299520. eCollection 2024.
8
A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.一种新型的 COVID-19 变体,Eris,可能是 2023 年需要关注的对象,亦或尚未结束。
Infect Disord Drug Targets. 2024;24(6):e220124225916. doi: 10.2174/0118715265276833240105110046.
9
Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology.在墨西哥第四波新冠疫情期间,利用基于污水的流行病学方法对奥密克戎和德尔塔变异株的流行情况进行检测与识别。
IJID Reg. 2023 Nov 10;10:44-51. doi: 10.1016/j.ijregi.2023.11.005. eCollection 2024 Mar.
10
Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan.脸书上具有说服力的新冠疫苗接种宣传活动以及乌克兰、印度和巴基斯坦的全国疫苗接种覆盖率。
PLOS Glob Public Health. 2023 Sep 27;3(9):e0002357. doi: 10.1371/journal.pgph.0002357. eCollection 2023.

奥密克戎和德尔塔变异株的双重组合引发了 COVID-19 病例的海啸式高浪:这是一个具有挑战性的全球威胁,特别关注印度次大陆。

Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID-19 cases: A challenging global threat with a special focus on the Indian subcontinent.

机构信息

Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.

Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, Uttar Pradesh, India.

出版信息

J Med Virol. 2022 May;94(5):1761-1765. doi: 10.1002/jmv.27585. Epub 2022 Feb 12.

DOI:10.1002/jmv.27585
PMID:35014038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9015634/
Abstract

The emergence of Omicron (B.1.1.529) variant of SARS-CoV-2 has resulted into a very massive surge in COVID-19 cases worldwide. Due to continuous emergence of multiple variants of SARS-CoV-2, the ongoing pandemic has caused severe morbidity and mortality in last two years. The rate of infectivity of Omicron variant is much higher than Delta variant and in a very quick time Omicron has displaced the Delta variant and now become a dominant variant across the globe. The twin combination of Omicron and Delta variant is triggering a Tsunami wave of ever high surges in COVID-19 cases worldwide. This article highlights the global threats and challenges posed by Omicron, and strategies to counter it with a particular focus on Indian sub-continent.

摘要

奥密克戎(B.1.1.529)变异株的出现导致了全球 COVID-19 病例的大规模激增。由于 SARS-CoV-2 的多个变异株不断出现,过去两年大流行导致了严重的发病率和死亡率。奥密克戎变异株的传染性率远高于德尔塔变异株,奥密克戎在很短的时间内取代了德尔塔变异株,现在成为全球的主要变异株。奥密克戎和德尔塔变异株的双重组合正在引发全球 COVID-19 病例的海啸式高增长。本文重点介绍了奥密克戎带来的全球威胁和挑战,并特别关注印度次大陆的应对策略。